Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Andrew Read to Join Board of Directors of International Endeavors Corporation


Posted on: 05 Mar 18

TEMECULA, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--- International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announced that Andrew Read has agreed to join the company’s Board of directors. Read most recently served as president of Voltage River, a boutique energy services company providing energy management solutions to businesses and home owners in California.

“Andrew brings with him the expertise we need to move into the energy segment of the Medical Marijuana industry and is passionate about clean energy. His expertise in the solar industry will be extremely valuable to customers as we prepare to enter the energy segment of the MMJ industry. We are excited to welcome him to the board.” stated Nathan Engal, President of International Endeavors Corporation.

Andrew has been involved in the clean energy industry since 2003 and founded Voltage River in 2011. Andrew has designed and built hundreds of solar electric and battery systems for commercial and residential use, the core focus has been to reduce electricity costs by leveraging the benefits of solar electric and advanced energy storage systems. Andrew brings considerable knowledge focusing on applying his skills to help growers develop a means of cutting energy costs and expand opportunities for off the grid growing facilities for the cannabis industry.

About International Endeavors Corporation
International Endeavors Corporation is a company focused on building IP in the Medical Marijuana Sector through the creation of biomedical devices, clean energy and patents. www.internationalendeavorscorp.com

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Nate Engel
CEO
Phone: 951-296-1024
Email: nate@internationalendeavorscorp.com

GlobeNewswire
globenewswire.com

Last updated on: 05/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.